These final experiments were prompted by reports that SCN5A mutations are associated with not only with Brugada Syndrome (BrS), but also with progressive cardiac conduction defect (PCCD)/Lev–Lenegre disease. The gene discussed is SCN5A; the disease is cardiac conduction defect.